{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:02:21Z","timestamp":1791655341392,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200777"],"award-info":[{"award-number":["82200777"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100803"],"award-info":[{"award-number":["82100803"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023020201020505"],"award-info":[{"award-number":["2023020201020505"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ40710"],"award-info":[{"award-number":["2022JJ40710"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2021CFB379"],"award-info":[{"award-number":["2021CFB379"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2021CFB101"],"award-info":[{"award-number":["2021CFB101"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bbadis.2024.167433","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T09:21:37Z","timestamp":1721985697000},"page":"167433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Dapagliflozin attenuates AKI to CKD transition in diabetes by activating SIRT3\/PGC1-\u03b1 signaling and alleviating aberrant metabolic reprogramming"],"prefix":"10.1016","volume":"1870","author":[{"given":"Huimin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchu","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaYi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiefu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10027","key":"10.1016\/j.bbadis.2024.167433_bb0005","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants","volume":"387","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bbadis.2024.167433_bb0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","article-title":"Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention","volume":"20","author":"Wong","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167433_bb0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/CIR.0000000000001145","article-title":"Epidemiology of diabetes and atherosclerotic cardiovascular disease among Asian American adults: implications, management, and future directions: a scientific statement from the American Heart Association","volume":"148","author":"Kwan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2024.167433_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"3 Suppl 1","key":"10.1016\/j.bbadis.2024.167433_bb0025","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2016.12.004","article-title":"US renal data system 2016 annual data report: epidemiology of kidney disease in the United States","volume":"69","author":"Saran","year":"2017","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167433_bb0030","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201340RR","article-title":"Acute kidney injury in diabetes mellitus: epidemiology, diagnostic, and therapeutic concepts","volume":"37","author":"Gui","year":"2023","journal-title":"FASEB J."},{"issue":"13","key":"10.1016\/j.bbadis.2024.167433_bb0035","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1074\/jbc.M117.779520","article-title":"SGLT2 protein expression is increased in human diabetic nephropathy: SGLT2 protein inhibition decreases renal lipid accumulation, inflammation, and the development of nephropathy in diabetic mice","volume":"292","author":"Wang","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167433_bb0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.kint.2020.02.041","article-title":"The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors?","volume":"98","author":"Hesp","year":"2020","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167433_bb0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.34067\/KID.0004772020","article-title":"Proximal tubular oxidative metabolism in acute kidney injury and the transition to CKD","volume":"2","author":"Schaub","year":"2021","journal-title":"Kidney360"},{"key":"10.1016\/j.bbadis.2024.167433_bb0050","article-title":"Fatty acid \u03b2-oxidation in kidney diseases: perspectives on pathophysiological mechanisms and therapeutic opportunities","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2024.167433_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155194","article-title":"Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming","volume":"131","author":"Zhu","year":"2022","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.bbadis.2024.167433_bb0060","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165654","article-title":"Molecular pathways that drive diabetic kidney disease","volume":"133","author":"Mohandes","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2024.167433_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104600","article-title":"Mitochondrial carnitine palmitoyltransferase 2 is involved in N(\u03b5)-(carboxymethyl)-lysine-mediated diabetic nephropathy","volume":"152","author":"Lee","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbadis.2024.167433_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155195","article-title":"Mitochondrial dysfunction in diabetic tubulopathy","volume":"131","author":"Yao","year":"2022","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.bbadis.2024.167433_bb0075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.ackd.2017.12.005","article-title":"Acute kidney injury and progression of diabetic kidney disease","volume":"25","author":"Yu","year":"2018","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.bbadis.2024.167433_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154799","article-title":"Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists","volume":"120","author":"Prattichizzo","year":"2021","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.bbadis.2024.167433_bb0085","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1681\/ASN.2022050623","article-title":"Treatment effect of the SGLT2 inhibitor empagliflozin on chronic syndrome of inappropriate antidiuresis: results of a randomized, double-blind, placebo-controlled","volume":"34","author":"Refardt","year":"2023","journal-title":"Crossover Trial. J Am Soc Nephrol."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167433_bb0090","doi-asserted-by":"crossref","first-page":"F1041","DOI":"10.1152\/ajprenal.00512.2019","article-title":"Canagliflozin reduces cisplatin uptake and activates Akt to protect against cisplatin-induced nephrotoxicity","volume":"318","author":"Song","year":"2020","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167433_bb0095","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1681\/ASN.2022030306","article-title":"Correlates and consequences of an acute change in eGFR in response to the SGLT2 inhibitor dapagliflozin in patients with CKD","volume":"33","author":"Jongs","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.bbadis.2024.167433_bb0100","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1681\/ASN.2021070935","article-title":"Dapagliflozin prevents kidney glycogen accumulation and improves renal proximal tubule cell functions in a mouse model of glycogen storage disease type 1b","volume":"33","author":"D\u2019Acierno","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"issue":"14","key":"10.1016\/j.bbadis.2024.167433_bb0105","doi-asserted-by":"crossref","first-page":"E351","DOI":"10.1503\/cmaj.191283","article-title":"Use of sodium-glucose cotransporter-2 inhibitors and risk of acute kidney injury in older adults with diabetes: a population-based cohort study","volume":"192","author":"Iskander","year":"2020","journal-title":"Cmaj"},{"issue":"3","key":"10.1016\/j.bbadis.2024.167433_bb0110","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/jamainternmed.2022.6664","article-title":"Comparing effectiveness and safety of SGLT2 inhibitors vs DPP-4 inhibitors in patients with type 2 diabetes and varying baseline HbA1c levels","volume":"183","author":"D\u2019Andrea","year":"2023","journal-title":"JAMA Intern. Med."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167433_bb0115","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2021.09.015","article-title":"SGLT2 inhibitors and the risk of acute kidney injury in older adults with type 2 diabetes","volume":"79","author":"Zhuo","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbadis.2024.167433_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122095","article-title":"Phloretin as an add-on therapy to losartan attenuates diabetes-induced AKI in rats: a potential therapeutic approach targeting TLR4-induced inflammation","volume":"332","author":"Shelke","year":"2023","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167433_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152153","article-title":"Unilateral renal ischemia-reperfusion as a robust model for acute to chronic kidney injury in mice","volume":"11","author":"Le Clef","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167433_bb0130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ki.2014.226","article-title":"Hyperglycemia, p53, and mitochondrial pathway of apoptosis are involved in the susceptibility of diabetic models to ischemic acute kidney injury","volume":"87","author":"Peng","year":"2015","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.bbadis.2024.167433_bb0135","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1681\/ASN.2019101060","article-title":"Protein kinase C-\u03b4 mediates kidney tubular injury in cold storage-associated kidney transplantation","volume":"31","author":"Zhu","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.bbadis.2024.167433_bb0140","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1681\/ASN.0000000000000154","article-title":"miR-147 represses NDUFA4, inducing mitochondrial dysfunction and tubular damage in cold storage kidney transplantation","volume":"34","author":"Zhu","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167433_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajt.2022.09.003","article-title":"MiR-20a-5p alleviates kidney ischemia\/reperfusion injury by targeting ACSL4-dependent ferroptosis","volume":"23","author":"Shi","year":"2023","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167433_bb0150","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.kint.2019.09.013","article-title":"The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial","volume":"97","author":"van Bommel","year":"2020","journal-title":"Kidney Int."},{"issue":"7595","key":"10.1016\/j.bbadis.2024.167433_bb0155","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature17184","article-title":"PGC1\u03b1 drives NAD biosynthesis linking oxidative metabolism to renal protection","volume":"531","author":"Tran","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbadis.2024.167433_bb0160","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/ki.2015.157","article-title":"Sirtuin and metabolic kidney disease","volume":"88","author":"Wakino","year":"2015","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.bbadis.2024.167433_bb0165","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1464-5491.2011.03498.x","article-title":"Risk of acute renal failure in patients with type 2 diabetes mellitus","volume":"29","author":"Girman","year":"2012","journal-title":"Diabet. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167433_bb0170","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1681\/ASN.2020030323","article-title":"The relationship between AKI and CKD in patients with type 2 diabetes: an observational cohort study","volume":"32","author":"Hapca","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.bbadis.2024.167433_bb0175","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.2337\/dc17-2409","article-title":"New-onset diabetes after acute kidney injury requiring dialysis","volume":"41","author":"Lin","year":"2018","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.bbadis.2024.167433_bb0180","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.metabol.2014.06.013","article-title":"The PI3K\/p-Akt signaling pathway participates in calcitriol ameliorating podocyte injury in DN rats","volume":"63","author":"Song","year":"2014","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.bbadis.2024.167433_bb0185","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/CIRCULATIONAHA.108.191305","volume":"119","author":"Skyler","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bbadis.2024.167433_bb0190","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.2215\/CJN.01120211","article-title":"Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus","volume":"6","author":"Thakar","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167433_bb0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13098-022-00971-1","article-title":"Development and validation of short-term renal prognosis prediction model in diabetic patients with acute kidney injury","volume":"14","author":"Mo","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"issue":"32","key":"10.1016\/j.bbadis.2024.167433_bb0200","doi-asserted-by":"crossref","first-page":"53028","DOI":"10.18632\/oncotarget.18081","article-title":"Dipeptidyl peptidase 4 inhibitor use is associated with a lower risk of incident acute kidney injury in patients with diabetes","volume":"8","author":"Chao","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.bbadis.2024.167433_bb0205","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.mayocp.2018.06.023","article-title":"Improvement in mortality and end-stage renal disease in patients with type 2 diabetes after acute kidney injury who are prescribed dipeptidyl peptidase-4 inhibitors","volume":"93","author":"Chen","year":"2018","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167433_bb0210","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.0453","article-title":"Sodium-glucose transport protein 2 inhibitor use for type 2 diabetes and the incidence of acute kidney injury in Taiwan","volume":"6","author":"Chung","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"10.1016\/j.bbadis.2024.167433_bb0215","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164486","article-title":"SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes","volume":"133","author":"Schaub","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167433_bb0220","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1016\/j.apsb.2021.05.013","article-title":"Spatial-resolved metabolomics reveals tissue-specific metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.bbadis.2024.167433_bb0225","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrneph.2016.186","article-title":"Metabolic reprogramming and tolerance during sepsis-induced AKI","volume":"13","author":"G\u00f3mez","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"8","key":"10.1016\/j.bbadis.2024.167433_bb0230","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ndt\/gft101","article-title":"\u2018Biologic memory\u2019 in response to acute kidney injury: cytoresistance, toll-like receptor hyper-responsiveness and the onset of progressive renal disease","volume":"28","author":"Zager","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167433_bb0235","doi-asserted-by":"crossref","first-page":"F561","DOI":"10.1152\/ajprenal.00036.2017","article-title":"Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis","volume":"313","author":"Ding","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167433_bb0240","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.bbadis.2024.167433_bb0245","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140695","article-title":"Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis","volume":"131","author":"Miguel","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167433_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/biom10020347","article-title":"The role of PGC-1\u03b1 and mitochondrial biogenesis in kidney diseases","volume":"10","author":"Fontecha-Barriuso","year":"2020","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.bbadis.2024.167433_bb0255","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.cmet.2015.03.007","article-title":"SIRT3 mediates multi-tissue coupling for metabolic fuel switching","volume":"21","author":"Dittenhafer-Reed","year":"2015","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.bbadis.2024.167433_bb0260","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nrg3275","article-title":"Human mitochondrial DNA: roles of inherited and somatic mutations","volume":"13","author":"Schon","year":"2012","journal-title":"Nat. Rev. Genet."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167433_bb0265","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1681\/ASN.2017111218","article-title":"Sirtuins in renal health and disease","volume":"29","author":"Morigi","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"38","key":"10.1016\/j.bbadis.2024.167433_bb0270","doi-asserted-by":"crossref","first-page":"14447","DOI":"10.1073\/pnas.0803790105","article-title":"A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis","volume":"105","author":"Ahn","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167433_bb0275","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1083\/jcb.201404118","article-title":"Drosophila Sirt2\/mammalian SIRT3 deacetylates ATP synthase \u03b2 and regulates complex V activity","volume":"206","author":"Rahman","year":"2014","journal-title":"J. Cell Biol."},{"issue":"35","key":"10.1016\/j.bbadis.2024.167433_bb0280","doi-asserted-by":"crossref","first-page":"14608","DOI":"10.1073\/pnas.1111308108","article-title":"Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production","volume":"108","author":"Jing","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/j.bbadis.2024.167433_bb0285","doi-asserted-by":"crossref","first-page":"13560","DOI":"10.1074\/jbc.M414670200","article-title":"SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes","volume":"280","author":"Shi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2024.167433_bb0290","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.freeradbiomed.2013.05.002","article-title":"SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage","volume":"63","author":"Tseng","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167433_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.08.003","article-title":"Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis","volume":"30","author":"Chung","year":"2019","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.bbadis.2024.167433_bb0300","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1021\/acs.jproteome.8b00260","article-title":"SIRT3 overexpression inhibits growth of kidney tumor cells and enhances mitochondrial biogenesis","volume":"17","author":"Liu","year":"2018","journal-title":"J. Proteome Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924004265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924004265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T17:14:28Z","timestamp":1759425268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443924004265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0925443924004265"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167433","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapagliflozin attenuates AKI to CKD transition in diabetes by activating SIRT3\/PGC1-\u03b1 signaling and alleviating aberrant metabolic reprogramming","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167433"}}